Yi Chen's Stock Ratings

HC Wainwright & Co. Analyst

Yi Chen is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/01/2024

Overall Average Return

5.12%

Smart Score

58.2%

Overall Average Return Percentile

49th

Number of Ratings

349
Buy NowGet Alert
05/31/2024CDNABuy Now
CareDx
$13.01——Reiterates → NeutralGet Alert
05/30/2024OCSBuy Now
Oculis Holding
$11.76138.1%$28 → $28ReiteratesBuy → BuyGet Alert
05/29/2024ICCMBuy Now
Icecure Medical
$1.06183.02%$3 → $3ReiteratesBuy → BuyGet Alert
05/22/2024GLSIBuy Now
Greenwich LifeSciences
$13.76161.57% → $36ReiteratesBuy → BuyGet Alert
05/22/2024ANGOBuy Now
AngioDynamics
$6.31121.87% → $14ReiteratesBuy → BuyGet Alert
05/22/2024DRTSBuy Now
Alpha Tau Medical
$2.63242.21% → $9ReiteratesBuy → BuyGet Alert
05/20/2024KPRXBuy Now
Kiora Pharmaceuticals
$0.50303.96% → $2ReiteratesBuy → BuyGet Alert
05/17/2024GNPXBuy Now
Genprex
$3.65173.97% → $10ReiteratesBuy → BuyGet Alert
05/17/2024KALABuy Now
Kala Bio
$6.30185.71%$21 → $18MaintainsBuyGet Alert
05/16/2024BRNSBuy Now
Barinthus Biotherapeutics
$2.35240.43% → $8ReiteratesBuy → BuyGet Alert
05/16/2024ALIMBuy Now
Alimera Sciences
$2.96102.7% → $6ReiteratesBuy → BuyGet Alert
05/16/2024DRTSBuy Now
Alpha Tau Medical
$2.63242.21% → $9ReiteratesBuy → BuyGet Alert
05/15/2024CDNABuy Now
CareDx
$13.01——Reiterates → NeutralGet Alert
05/15/2024RGNXBuy Now
Regenxbio
$14.35164.81%$36 → $38MaintainsBuyGet Alert
05/15/2024GNPXBuy Now
Genprex
$3.65173.97% → $10ReiteratesBuy → BuyGet Alert
05/15/2024BLTEBuy Now
Belite Bio
$48.9520.53% → $59ReiteratesBuy → BuyGet Alert
05/14/2024TRMLBuy Now
Tourmaline Bio
$13.77248.58% → $48ReiteratesBuy → BuyGet Alert
05/13/2024APDNBuy Now
Applied DNA Sciences
$0.601066.67%$1.5 → $7MaintainsBuyGet Alert
05/13/2024OCSBuy Now
Oculis Holding
$11.76138.1%$28 → $28ReiteratesBuy → BuyGet Alert
05/13/2024CODXBuy Now
Co-Diagnostics
$1.0590.48%$2.5 → $2MaintainsNeutralGet Alert
05/13/2024SRTSBuy Now
Sensus Healthcare
$5.4583.49%$8 → $10MaintainsBuyGet Alert
05/13/2024EYPTBuy Now
EyePoint Pharmaceuticals
$11.00172.73%$33 → $30MaintainsBuyGet Alert
05/13/2024CLSDBuy Now
Clearside Biomedical
$1.40257.14%$6 → $5MaintainsBuyGet Alert
05/13/2024VERUBuy Now
Veru
$1.02194.12% → $3ReiteratesBuy → BuyGet Alert
05/10/2024LFMDBuy Now
LifeMD
$8.2545.45% → $12ReiteratesBuy → BuyGet Alert
05/08/2024OCULBuy Now
Ocular Therapeutix
$5.70145.61%$16 → $14MaintainsBuyGet Alert
05/08/2024OPKBuy Now
OPKO Health
$1.40114.29% → $3ReiteratesBuy → BuyGet Alert
05/06/2024VERUBuy Now
Veru
$1.02194.12%$2 → $3MaintainsBuyGet Alert
05/03/2024ASLNBuy Now
ASLAN Pharma
$0.431998.39% → $9ReiteratesBuy → BuyGet Alert
05/02/2024BLCOBuy Now
Bausch & Lomb
$15.2131.49% → $20ReiteratesBuy → BuyGet Alert

Recent Analyst Stock Rating News

Evaluating Regenxbio: Insights From 9 Financial Analysts
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings)
Critical Insights From Veru Analyst Ratings: What You Need To Know
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
Where Regenxbio Stands With Analysts
Critical Insights From OPKO Health Analyst Ratings: What You Need To Know
Decoding 6 Analyst Evaluations For Ocular Therapeutix
Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free